The management of retinal vein occlusion (RVO) has changed dramatically over the last 3 decades since the results of the Branch Vein Occlusion Study (BVOS) and Central Vein Occlusion Study (CVOS) were published in the 1980s and 1990s.
While most patients who present with RVO are 60 years of age or older, young patients can pose particular diagnostic and treatment challenges.
In this installment of Practical Retina, current RGW retina fellow Dr. Luke Lindsell and Dr. Michael Lai from Washington, D.C., address what should be included in an appropriate diagnostic work-up for younger patients who present with RVO, provide pearls for detecting uncommon underlying systemic etiologies, and review their treatment paradigm.
You can read about it in their article entitled “Current concepts in managing retinal vein occlusion in young patients” for the July/August 2015 issue of the journal Ophthalmic Surgery Lasers & Imaging Retina.
Click here to read more.
Source: Ophthalmic Surgery, Lasers and Imaging Retina July 2015 – Volume 46 · Issue 7: 695-701
Below is an excerpt from the article quoting Dr. Johnson as a consulting retinal surgeon. Click on the link below to read the full article:
Dr Silva noted, however, that the cost of ultrawide field imaging devices at the present time “is prohibitive,” especially in places with small populations and a limited number of diabetes patients. But prices will come down in time, he added.
Asked to comment, T Mark Johnson, MD, FRCSC, an attending surgeon at the Retina Group of Washington, DC, who was not involved in the study, agreed that the current costs of the cameras used in ultrawide field imaging, are “significant” and could therefore limit their use in screening programs.
And he claims that past studies have suggested that even three-field photography (just taking photos of the posterior pole of the retina) may be as good as ultrawide field imaging for screening for significant diabetic retinopathy. Therefore, more research is needed to justify the added costs of ultrawide field imaging, he pointed out.
See more: http://www.medscape.com/viewarticle/846470
Retina Group of Washington in Fredericksburg
Welcome to Retina Group of Washington, Fredericksburg location.
At The Retina Group of Washington, we focus on the care of retinal and macular diseases, and we have assembled nationally recognized experts as well as the most advanced diagnostic and treatment technology available to give you and your vision the best results modern medicine can provide. Your vision is your most precious sense, so if it is being threatened by an eye condition, you want to find the most qualified help available to protect it.
Dr. Lee, Fredericksburg Eye Doctor
Early diagnosis and treatment of vitreoretinal disease can mean the difference between great vision, good vision, and no vision after treatment. If you are experiencing the symptoms of a vitreal or retinal condition, it’s important to contact a qualified eye doctor in Fredericksburg right away. Our eye surgeons in Fredericksburg have extensive knowledge in retinal and macular diseases.
At Retina Group of Washington, we are one of the largest and most well respected retina groups in the country with 14 offices around Virginia, Maryland, and Washignton DC. We are one of a select number of practices that truly emphasizes the treatment of conditions affecting the retina and macula. Many other ophthalmologists in Virginia and from across the country trust us with cases requiring special care. Our team of retinal specialists is dedicated to patient care, and we have state of the art technology necessary to provide eye surgery for progressive eye diseases. Our team works concurrently with your doctors to explore options for the most advanced treatment for your eye disease.
1500 Dixon Street, Suite 204
Fredericksburg, VA 22401